Be Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Akornindia: trust score, financial health, credit view, compliance, directors, growth and distress signals - g…

2011-08-29 Hyderabad, Telangana Active Unlisted Active Compliant
Share
View plans
BP Be Pharmaceuticals Private Limited

Akornindia — 360° Intelligence Report

Generated from MCA filings & public records
76/100
Trust Score
Low Risk

Akornindia is assessed as Low Risk with a Trust Score of 76/100. Akornindia is an active private limited indian non-government company incorporated in 2011, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 13 Jun 2026 from the latest processed filings. Be Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
76/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
50/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
55/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 1 satisfied (20.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Icici Bank Limited1 48.0 cr
Compliance Score: 50/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 3 court forum(s).
  • 2 auditor resignation(s) filed - latest: M S K A & ASSOCIATES on 2024-04-19.
  • Delayed payments to MSME suppliers disclosed (46 disclosure(s)).
  • 1 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RUDARAJU ANAND KUMAR 01234567 Director 01/04/2018 6 yrs Approved
MAHIPAL REDDY SADDI 01234567 Director 01/04/2018 6 yrs Approved
MAHIMA DATLA 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Biological E Limited
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 4 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Biological E Limited Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 55 · Distress 90
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Net margin improved to 1.42.
Operating for 14+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Compliance score is weak (50/100).
2 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 3.16 cr.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence70/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment60/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view67/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
18 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
31 Mar 2021
Share transfer (FY 2021)
1000.00000000 shares to LIMITED E. BIOLOGICAL
Share transfer (FY 2021)
4851376.00000000 shares to LIMITED E. BIOLOGICAL
Share transfer (FY 2021)
1.00000000 shares to MAHIMA DATLA
Share transfer (FY 2021)
157684.00000000 shares to LIMITED E. BIOLOGICAL
04 Sep 2020
Director ceased
MAHIPAL REDDY SADDI
26 Aug 2020
Director appointed
MAHIPAL REDDY SADDI (Director)
17 Aug 2020
Director ceased
RUDARAJU ANAND KUMAR
Director ceased
MAHIMA DATLA
14 Aug 2020
Director appointed
RUDARAJU ANAND KUMAR (Director)
Director appointed
MAHIMA DATLA (Director)
Director ceased
DHEERAJ CHOPRA
Director ceased
JOSEPH PATRICK BONACCORSI
23 Sep 2019
Director ceased
JOHN ANTHONY VALLEY
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Kph Cosmos Private Limited U24232UR2005PTC030306 Hardwar, Uttarakhand, India
Ullmann Laboratories Private Limited U85100MH2010PTC202922 Aurangabad, Maharashtra, India
Janani Pharmaceuticals Private Limited U51397TN2001PTC047192 Chennai-600097., Tamil Nadu, India
Acume Chemicals Private Limited U24290TN2021PTC148007 Chennai, Tamil Nadu, India
Upzon Drugs Private Limited U24232MP1996PTC010942 Indore, Madhya Pradesh, India
Polytek Synergy Limited U24290DL2022PLC397821 Delhi, Delhi, India
Nanghavi Chromatography Solutions Private Limited U24304MH2017PTC301383 Mumbai, Maharashtra, India
Medzone Pharmaceuticals U24232PY2010PTC002426 Pondicherry, Pondicherry, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Akornindia before audits and certifications: compliance score 50/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Akornindia: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 55/100, margin trends, ownership structure and peer set for Akornindia - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 76/100, distress signals and MSME payment-delay disclosures - know whether Akornindia pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Akornindia - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Akornindia an active company?

Akornindia has MCA status “Active” with a compliance score of 50/100 (Moderate).

Is Akornindia financially healthy?

Akornindia has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Akornindia?

Its overall Trust Score is 76/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Akornindia?

The ultimate holding entity is Biological E Limited. 3 active director(s) are on record.

Does Akornindia have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Akornindia up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 50/100 (Moderate).

Is it risky to lend to Akornindia?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.